Item 1. FINANCIAL STATEMENTS
160K characters. Original on sec.gov ·
Item 1. FINANCIAL STATEMENTS
Dow Inc. and Subsidiaries
Consolidated Statements of Income
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions, except per share amounts (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Net sales | $ | 10,104 | $ | 10,915 | $ | 20,535 | $ | 21,680 | ||||||
| Cost of sales | 9,521 | 9,591 | 19,281 | 19,079 | ||||||||||
| Research and development expenses | 188 | 196 | 388 | 400 | ||||||||||
| Selling, general and administrative expenses | 347 | 390 | 713 | 832 | ||||||||||
| Amortization of intangibles | 63 | 77 | 139 | 158 | ||||||||||
| Restructuring and asset related charges - net | 591 | — | 799 | 45 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | (30) | 26 | (50) | 43 | ||||||||||
| Sundry income (expense) - net | 147 | 76 | 160 | 137 | ||||||||||
| Interest income | 39 | 42 | 67 | 107 | ||||||||||
| Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 | ||||||||||
| Income (loss) before income taxes | (659) | 608 | (1,033) | 1,057 | ||||||||||
| Provision for income taxes | 142 | 150 | 58 | 61 | ||||||||||
| Net income (loss) | (801) | 458 | (1,091) | 996 | ||||||||||
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 | ||||||||||
| Net income (loss) available for Dow Inc. common stockholders | $ | (835) | $ | 439 | $ | (1,142) | $ | 955 | ||||||
| Per common share data: | ||||||||||||||
| Earnings (loss) per common share - basic | $ | (1.18) | $ | 0.62 | $ | (1.62) | $ | 1.35 | ||||||
| Earnings (loss) per common share - diluted | $ | (1.18) | $ | 0.62 | $ | (1.62) | $ | 1.35 | ||||||
| Weighted-average common shares outstanding - basic | 709.5 | 703.8 | 708.2 | 704.1 | ||||||||||
| Weighted-average common shares outstanding - diluted | 709.5 | 705.3 | 708.2 | 705.5 | ||||||||||
| Depreciation | $ | 538 | $ | 488 | $ | 1,050 | $ | 969 | ||||||
| Capital expenditures | $ | 662 | $ | 723 | $ | 1,347 | $ | 1,437 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Net income (loss) | $ | (801) | $ | 458 | $ | (1,091) | $ | 996 | ||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Unrealized gains (losses) on investments | (22) | 61 | 10 | 55 | ||||||||||
| Cumulative translation adjustments | 129 | (43) | 251 | (165) | ||||||||||
| Pension and other postretirement benefit plans | 21 | 17 | 41 | 34 | ||||||||||
| Derivative instruments | 2 | (6) | (18) | (28) | ||||||||||
| Total other comprehensive income (loss) | 130 | 29 | 284 | (104) | ||||||||||
| Comprehensive income (loss) | (671) | 487 | (807) | 892 | ||||||||||
| Comprehensive income attributable to noncontrolling interests, net of tax | 34 | 19 | 51 | 41 | ||||||||||
| Comprehensive income (loss) attributable to Dow Inc. | $ | (705) | $ | 468 | $ | (858) | $ | 851 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Balance Sheets
| In millions, except share amounts (Unaudited) | Jun 30, 2025 | Dec 31, 2024 | ||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 2,399 | $ | 2,189 | ||||
| Accounts and notes receivable: | ||||||||
| Trade (net of allowance for doubtful receivables - 2025: $72; 2024: $95) | 5,426 | 4,756 | ||||||
| Other | 2,228 | 2,108 | ||||||
| Inventories | 6,701 | 6,544 | ||||||
| Other current assets | 958 | 993 | ||||||
| Total current assets (variable interest entities restricted - 2025: $209; 2024: $55) | 17,712 | 16,590 | ||||||
| Investments | ||||||||
| Investment in nonconsolidated affiliates | 1,262 | 1,266 | ||||||
| Other investments (investments carried at fair value - 2025: $2,033; 2024: $2,047) | 2,788 | 3,033 | ||||||
| Noncurrent receivables | 434 | 380 | ||||||
| Total investments | 4,484 | 4,679 | ||||||
| Property | ||||||||
| Property | 64,860 | 62,121 | ||||||
| Less: Accumulated depreciation | 42,384 | 40,117 | ||||||
| Net property (variable interest entities restricted - 2025: $2,380; 2024: $122) | 22,476 | 22,004 | ||||||
| Other Assets | ||||||||
| Goodwill | 8,698 | 8,565 | ||||||
| Other intangible assets (net of accumulated amortization - 2025: $5,660; 2024: $5,394) | 1,606 | 1,721 | ||||||
| Operating lease right-of-use assets | 1,246 | 1,268 | ||||||
| Deferred income tax assets | 1,424 | 1,257 | ||||||
| Deferred charges and other assets | 1,345 | 1,228 | ||||||
| Total other assets (variable interest entities restricted - 2025: $212; 2024: $15) | 14,319 | 14,039 | ||||||
| Total Assets | $ | 58,991 | $ | 57,312 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities | ||||||||
| Notes payable | $ | 149 | $ | 135 | ||||
| Long-term debt due within one year | 401 | 497 | ||||||
| Accounts payable: | ||||||||
| Trade | 4,944 | 4,847 | ||||||
| Other | 1,697 | 1,694 | ||||||
| Operating lease liabilities - current | 325 | 318 | ||||||
| Income taxes payable | 314 | 276 | ||||||
| Accrued and other current liabilities | 2,656 | 2,521 | ||||||
| Total current liabilities (variable interest entities nonrecourse - 2025: $365; 2024: $24) | 10,486 | 10,288 | ||||||
| Long-Term Debt (variable interest entities nonrecourse - 2025: $176; 2024: $—) | 16,247 | 15,711 | ||||||
| Other Noncurrent Liabilities | ||||||||
| Deferred income tax liabilities | 378 | 392 | ||||||
| Pension and other postretirement benefits - noncurrent | 4,765 | 4,736 | ||||||
| Asbestos-related liabilities - noncurrent | 665 | 713 | ||||||
| Operating lease liabilities - noncurrent | 982 | 984 | ||||||
| Other noncurrent obligations | 6,876 | 6,637 | ||||||
| Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $329; 2024: $13) | 13,666 | 13,462 | ||||||
| Stockholders’ Equity | ||||||||
| Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2025: 785,942,132 shares; 2024: 784,471,939 shares) | 8 | 8 | ||||||
| Additional paid-in capital | 10,758 | 9,203 | ||||||
| Retained earnings | 18,766 | 20,909 | ||||||
| Accumulated other comprehensive loss | (7,826) | (8,110) | ||||||
| Treasury stock at cost (2025: 77,097,981 shares; 2024: 80,859,145 shares) | (4,475) | (4,655) | ||||||
| Dow Inc.’s stockholders’ equity | 17,231 | 17,355 | ||||||
| Noncontrolling interests | 1,361 | 496 | ||||||
| Total equity | 18,592 | 17,851 | ||||||
| Total Liabilities and Equity | $ | 58,991 | $ | 57,312 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows
| In millions (Unaudited) | Six Months Ended | |||||||
| Jun 30, 2025 | Jun 30, 2024 | |||||||
| Operating Activities | ||||||||
| Net income (loss) | $ | (1,091) | $ | 996 | ||||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | ||||||||
| Depreciation and amortization | 1,438 | 1,402 | ||||||
| Provision (credit) for deferred income tax | (131) | 28 | ||||||
| Earnings of nonconsolidated affiliates less than dividends received | 220 | 156 | ||||||
| Net periodic pension benefit credit | (50) | (95) | ||||||
| Pension contributions | (76) | (63) | ||||||
| Net gain on sales of assets, businesses and investments | (102) | (20) | ||||||
| Restructuring and asset related charges - net | 799 | 45 | ||||||
| Other net loss | 104 | 155 | ||||||
| Changes in assets and liabilities, net of effects of acquired and divested companies: | ||||||||
| Accounts and notes receivable | (935) | (485) | ||||||
| Inventories | (158) | (383) | ||||||
| Accounts payable | (12) | 544 | ||||||
| Other assets and liabilities, net | (372) | (988) | ||||||
| Cash provided by (used for) operating activities - continuing operations | (366) | 1,292 | ||||||
| Cash provided by (used for) operating activities - discontinued operations | (13) | 8 | ||||||
| Cash provided by (used for) operating activities | (379) | 1,300 | ||||||
| Investing Activities | ||||||||
| Capital expenditures | (1,347) | (1,437) | ||||||
| Investment in gas field developments | (68) | (96) | ||||||
| Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 131 | 8 | ||||||
| Investments in and loans to nonconsolidated affiliates | (20) | (4) | ||||||
| Purchases of investments | (205) | (1,072) | ||||||
| Proceeds from sales and maturities of investments | 552 | 1,824 | ||||||
| Other investing activities, net | (5) | 12 | ||||||
| Cash used for investing activities | (962) | (765) | ||||||
| Financing Activities | ||||||||
| Changes in short-term notes payable | 48 | 26 | ||||||
| Proceeds from issuance of short-term debt greater than three months | 37 | 40 | ||||||
| Payments on short-term debt greater than three months | (41) | — | ||||||
| Proceeds from issuance of long-term debt | 1,107 | 1,396 | ||||||
| Payments on long-term debt | (1,114) | (183) | ||||||
| Collections on securitization programs, net of remittances | 18 | 21 | ||||||
| Purchases of treasury stock | — | (400) | ||||||
| Proceeds from issuance of stock | — | 51 | ||||||
| Transaction financing, debt issuance and other costs | (85) | (11) | ||||||
| Employee taxes paid for share-based payment arrangements | (16) | (38) | ||||||
| Distributions to noncontrolling interests | (56) | (47) | ||||||
| Proceeds from sale of noncontrolling interests | 2,433 | — | ||||||
| Dividends paid to stockholders | (990) | (984) | ||||||
| Cash provided by (used for) financing activities | 1,341 | (129) | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 253 | (69) | ||||||
| Summary | ||||||||
| Increase in cash, cash equivalents and restricted cash | 253 | 337 | ||||||
| Cash, cash equivalents and restricted cash at beginning of period | 2,263 | 3,048 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 2,516 | $ | 3,385 | ||||
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 117 | 44 | ||||||
| Cash and cash equivalents at end of period | $ | 2,399 | $ | 3,341 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Equity
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions, except per share amounts (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Common Stock | ||||||||||||||
| Balance at beginning and end of period | $ | 8 | $ | 8 | $ | 8 | $ | 8 | ||||||
| Additional Paid-in Capital | ||||||||||||||
| Balance at beginning of period | 9,195 | 8,942 | 9,203 | 8,880 | ||||||||||
| Common stock issued/sold | — | 9 | — | 51 | ||||||||||
| Stock-based compensation | 109 | 112 | 196 | 199 | ||||||||||
| Treasury stock issuances - compensation and benefit plans | (85) | (51) | (180) | (118) | ||||||||||
| Sale of membership interest in Diamond Infrastructure Solutions (Note 17) | 1,540 | — | 1,540 | — | ||||||||||
| Other | (1) | — | (1) | — | ||||||||||
| Balance at end of period | 10,758 | 9,012 | 10,758 | 9,012 | ||||||||||
| Retained Earnings | ||||||||||||||
| Balance at beginning of period | 20,101 | 21,796 | 20,909 | 21,774 | ||||||||||
| Net income (loss) available for Dow Inc. common stockholders | (835) | 439 | (1,142) | 955 | ||||||||||
| Dividends to stockholders | (496) | (491) | (990) | (984) | ||||||||||
| Common control transaction | — | — | — | 10 | ||||||||||
| Other | (4) | (5) | (11) | (16) | ||||||||||
| Balance at end of period | 18,766 | 21,739 | 18,766 | 21,739 | ||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||
| Balance at beginning of period | (7,956) | (7,814) | (8,110) | (7,681) | ||||||||||
| Other comprehensive income (loss) | 130 | 29 | 284 | (104) | ||||||||||
| Balance at end of period | (7,826) | (7,785) | (7,826) | (7,785) | ||||||||||
| Treasury Stock | ||||||||||||||
| Balance at beginning of period | (4,560) | (4,507) | (4,655) | (4,374) | ||||||||||
| Treasury stock purchases | — | (200) | — | (400) | ||||||||||
| Treasury stock issuances - compensation and benefit plans | 85 | 51 | 180 | 118 | ||||||||||
| Balance at end of period | (4,475) | (4,656) | (4,475) | (4,656) | ||||||||||
| Dow Inc.'s stockholders' equity | 17,231 | 18,318 | 17,231 | 18,318 | ||||||||||
| Noncontrolling Interests | 1,361 | 482 | 1,361 | 482 | ||||||||||
| Total Equity | $ | 18,592 | $ | 18,800 | $ | 18,592 | $ | 18,800 | ||||||
| Dividends declared per share of common stock | $ | 0.70 | $ | 0.70 | $ | 1.40 | $ | 1.40 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Net sales | $ | 10,104 | $ | 10,915 | $ | 20,535 | $ | 21,680 | ||||||
| Cost of sales | 9,520 | 9,590 | 19,279 | 19,077 | ||||||||||
| Research and development expenses | 188 | 196 | 388 | 400 | ||||||||||
| Selling, general and administrative expenses | 347 | 390 | 713 | 832 | ||||||||||
| Amortization of intangibles | 63 | 77 | 139 | 158 | ||||||||||
| Restructuring and asset related charges - net | 591 | — | 799 | 45 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | (30) | 26 | (50) | 43 | ||||||||||
| Sundry income (expense) - net | 163 | 74 | 176 | 135 | ||||||||||
| Interest income | 41 | 45 | 70 | 114 | ||||||||||
| Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 | ||||||||||
| Income (loss) before income taxes | (640) | 610 | (1,012) | 1,064 | ||||||||||
| Provision for income taxes | 142 | 150 | 58 | 61 | ||||||||||
| Net income (loss) | (782) | 460 | (1,070) | 1,003 | ||||||||||
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 | ||||||||||
| Net income (loss) available for The Dow Chemical Company common stockholder | $ | (816) | $ | 441 | $ | (1,121) | $ | 962 | ||||||
| Depreciation | $ | 538 | $ | 488 | $ | 1,050 | $ | 969 | ||||||
| Capital expenditures | $ | 662 | $ | 723 | $ | 1,347 | $ | 1,437 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Net income (loss) | $ | (782) | $ | 460 | $ | (1,070) | $ | 1,003 | ||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Unrealized gains (losses) on investments | (22) | 61 | 10 | 55 | ||||||||||
| Cumulative translation adjustments | 129 | (43) | 251 | (165) | ||||||||||
| Pension and other postretirement benefit plans | 21 | 17 | 41 | 34 | ||||||||||
| Derivative instruments | 2 | (6) | (18) | (28) | ||||||||||
| Total other comprehensive income (loss) | 130 | 29 | 284 | (104) | ||||||||||
| Comprehensive income (loss) | (652) | 489 | (786) | 899 | ||||||||||
| Comprehensive income attributable to noncontrolling interests, net of tax | 34 | 19 | 51 | 41 | ||||||||||
| Comprehensive income (loss) attributable to The Dow Chemical Company | $ | (686) | $ | 470 | $ | (837) | $ | 858 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
| In millions, except share amounts (Unaudited) | Jun 30, 2025 | Dec 31, 2024 | ||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 2,399 | $ | 2,189 | ||||
| Accounts and notes receivable: | ||||||||
| Trade (net of allowance for doubtful receivables - 2025: $72; 2024: $95) | 5,426 | 4,756 | ||||||
| Other | 2,236 | 2,116 | ||||||
| Inventories | 6,701 | 6,544 | ||||||
| Other current assets | 921 | 960 | ||||||
| Total current assets (variable interest entities restricted - 2025: $209; 2024: $55) | 17,683 | 16,565 | ||||||
| Investments | ||||||||
| Investment in nonconsolidated affiliates | 1,262 | 1,266 | ||||||
| Other investments (investments carried at fair value - 2025: $2,033; 2024: $2,047) | 2,788 | 3,033 | ||||||
| Noncurrent receivables | 427 | 374 | ||||||
| Total investments | 4,477 | 4,673 | ||||||
| Property | ||||||||
| Property | 64,860 | 62,121 | ||||||
| Less accumulated depreciation | 42,384 | 40,117 | ||||||
| Net property (variable interest entities restricted - 2025: $2,380; 2024: $122) | 22,476 | 22,004 | ||||||
| Other Assets | ||||||||
| Goodwill | 8,698 | 8,565 | ||||||
| Other intangible assets (net of accumulated amortization - 2025: $5,660; 2024: $5,394) | 1,606 | 1,721 | ||||||
| Operating lease right-of-use assets | 1,246 | 1,268 | ||||||
| Deferred income tax assets | 1,424 | 1,257 | ||||||
| Deferred charges and other assets | 1,345 | 1,228 | ||||||
| Total other assets (variable interest entities restricted - 2025: $212; 2024: $15) | 14,319 | 14,039 | ||||||
| Total Assets | $ | 58,955 | $ | 57,281 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities | ||||||||
| Notes payable | $ | 149 | $ | 135 | ||||
| Long-term debt due within one year | 401 | 497 | ||||||
| Accounts payable: | ||||||||
| Trade | 4,944 | 4,847 | ||||||
| Other | 1,714 | 1,732 | ||||||
| Operating lease liabilities - current | 325 | 318 | ||||||
| Income taxes payable | 314 | 276 | ||||||
| Accrued and other current liabilities | 2,535 | 2,405 | ||||||
| Total current liabilities (variable interest entities nonrecourse - 2025: $365; 2024: $24) | 10,382 | 10,210 | ||||||
| Long-Term Debt (variable interest entities nonrecourse - 2025: $176; 2024: $—) | 16,247 | 15,711 | ||||||
| Other Noncurrent Liabilities | ||||||||
| Deferred income tax liabilities | 378 | 392 | ||||||
| Pension and other postretirement benefits - noncurrent | 4,765 | 4,736 | ||||||
| Asbestos-related liabilities - noncurrent | 665 | 713 | ||||||
| Operating lease liabilities - noncurrent | 982 | 984 | ||||||
| Other noncurrent obligations | 6,737 | 6,503 | ||||||
| Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $329: 2024: $13) | 13,527 | 13,328 | ||||||
| Stockholder's Equity | ||||||||
| Common stock (authorized and issued 100 shares of $0.01 par value each) | — | — | ||||||
| Additional paid-in capital | 11,362 | 9,626 | ||||||
| Retained earnings | 13,902 | 16,020 | ||||||
| Accumulated other comprehensive loss | (7,826) | (8,110) | ||||||
| The Dow Chemical Company’s stockholder's equity | 17,438 | 17,536 | ||||||
| Noncontrolling interests | 1,361 | 496 | ||||||
| Total equity | 18,799 | 18,032 | ||||||
| Total Liabilities and Equity | $ | 58,955 | $ | 57,281 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
| In millions (Unaudited) | Six Months Ended | |||||||
| Jun 30, 2025 | Jun 30, 2024 | |||||||
| Operating Activities | ||||||||
| Net income (loss) | $ | (1,070) | $ | 1,003 | ||||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | ||||||||
| Depreciation and amortization | 1,438 | 1,402 | ||||||
| Provision (credit) for deferred income tax | (131) | 28 | ||||||
| Earnings of nonconsolidated affiliates less than dividends received | 220 | 156 | ||||||
| Net periodic pension benefit credit | (50) | (95) | ||||||
| Pension contributions | (76) | (63) | ||||||
| Net gain on sales of assets, businesses and investments | (102) | (20) | ||||||
| Restructuring and asset related charges - net | 799 | 45 | ||||||
| Other net loss | 105 | 156 | ||||||
| Changes in assets and liabilities, net of effects of acquired and divested companies: | ||||||||
| Accounts and notes receivable | (935) | (485) | ||||||
| Inventories | (158) | (383) | ||||||
| Accounts payable | (12) | 544 | ||||||
| Other assets and liabilities, net | (412) | (988) | ||||||
| Cash provided by (used for) operating activities | (384) | 1,300 | ||||||
| Investing Activities | ||||||||
| Capital expenditures | (1,347) | (1,437) | ||||||
| Investment in gas field developments | (68) | (96) | ||||||
| Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 131 | 8 | ||||||
| Investments in and loans to nonconsolidated affiliates | (20) | (4) | ||||||
| Purchases of investments | (205) | (1,072) | ||||||
| Proceeds from sales and maturities of investments | 552 | 1,824 | ||||||
| Other investing activities, net | (5) | 12 | ||||||
| Cash used for investing activities | (962) | (765) | ||||||
| Financing Activities | ||||||||
| Changes in short-term notes payable | 48 | 26 | ||||||
| Proceeds from issuance of short-term debt greater than three months | 37 | 40 | ||||||
| Payments on short-term debt greater than three months | (41) | — | ||||||
| Proceeds from issuance of long-term debt | 1,107 | 1,396 | ||||||
| Payments on long-term debt | (1,114) | (183) | ||||||
| Collections on securitization programs, net of remittances | 18 | 21 | ||||||
| Proceeds from issuance of stock | — | 51 | ||||||
| Transaction financing, debt issuance and other costs | (85) | (11) | ||||||
| Employee taxes paid for share-based payment arrangements | (16) | (38) | ||||||
| Distributions to noncontrolling interests | (56) | (47) | ||||||
| Proceeds from sale of noncontrolling interests | 2,433 | — | ||||||
| Dividends paid to Dow Inc. | (985) | (1,384) | ||||||
| Cash provided by (used for) financing activities | 1,346 | (129) | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 253 | (69) | ||||||
| Summary | ||||||||
| Increase in cash, cash equivalents and restricted cash | 253 | 337 | ||||||
| Cash, cash equivalents and restricted cash at beginning of period | 2,263 | 3,048 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 2,516 | $ | 3,385 | ||||
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 117 | 44 | ||||||
| Cash and cash equivalents at end of period | $ | 2,399 | $ | 3,341 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
| Three Months Ended | Six Months Ended | |||||||||||||
| In millions (Unaudited) | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Common Stock | ||||||||||||||
| Balance at beginning and end of period | $ | — | $ | — | $ | — | $ | — | ||||||
| Additional Paid-in Capital | ||||||||||||||
| Balance at beginning of period | 9,713 | 9,220 | 9,626 | 9,091 | ||||||||||
| Issuance of parent company stock - Dow Inc. | — | 9 | — | 51 | ||||||||||
| Stock-based compensation | 109 | 112 | 196 | 199 | ||||||||||
| Sale of membership interest in Diamond Infrastructure Solutions (Note 17) | 1,540 | — | 1,540 | — | ||||||||||
| Balance at end of period | 11,362 | 9,341 | 11,362 | 9,341 | ||||||||||
| Retained Earnings | ||||||||||||||
| Balance at beginning of period | 15,193 | 17,214 | 16,020 | 17,495 | ||||||||||
| Net income (loss) available for The Dow Chemical Company common stockholder | (816) | 441 | (1,121) | 962 | ||||||||||
| Dividends to Dow Inc. | (470) | (686) | (985) | (1,477) | ||||||||||
| Other | (5) | (5) | (12) | (16) | ||||||||||
| Balance at end of period | 13,902 | 16,964 | 13,902 | 16,964 | ||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||
| Balance at beginning of period | (7,956) | (7,814) | (8,110) | (7,681) | ||||||||||
| Other comprehensive income (loss) | 130 | 29 | 284 | (104) | ||||||||||
| Balance at end of period | (7,826) | (7,785) | (7,826) | (7,785) | ||||||||||
| The Dow Chemical Company's stockholder's equity | 17,438 | 18,520 | 17,438 | 18,520 | ||||||||||
| Noncontrolling Interests | 1,361 | 482 | 1,361 | 482 | ||||||||||
| Total Equity | $ | 18,799 | $ | 19,002 | $ | 18,799 | $ | 19,002 |
See Notes to the Consolidated Financial Statements.
| Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 10-K").
As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.
Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo, LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and became a consolidated variable interest entity effective May 1, 2025. See Notes 17 and 22 for additional information about Diamond Infrastructure Solutions.
NOTE 2 – RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. See Note 23 for applicable reportable segment disclosures required by this guidance.
Accounting Guidance Issued But Not Adopted at June 30, 2025
In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public business entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.
SEC Final Rules Not Adopted at June 30, 2025
In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the SEC voted to end its defense of the final rules; however, the Court of Appeals may still rule on the matter.
NOTE 3 – REVENUE
Revenue Recognition
The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent and 97 percent for the three and six months ended June 30, 2025, respectively (97 percent and 98 percent for the three and six months ended June 30, 2024, respectively). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At June 30, 2025, the Company had unfulfilled performance obligations of $762 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next five years.
The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:
| Net Trade Sales by Segment and Business | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Hydrocarbons & Energy | $ | 1,350 | $ | 1,447 | $ | 2,928 | $ | 2,914 | ||||||
| Packaging and Specialty Plastics | 3,675 | 4,068 | 7,407 | 8,031 | ||||||||||
| Packaging & Specialty Plastics | $ | 5,025 | $ | 5,515 | $ | 10,335 | $ | 10,945 | ||||||
| Industrial Solutions | $ | 985 | $ | 1,040 | $ | 2,039 | $ | 2,068 | ||||||
| Polyurethanes & Construction Chemicals | 1,797 | 1,909 | 3,594 | 3,886 | ||||||||||
| Other | 4 | 2 | 8 | 5 | ||||||||||
| Industrial Intermediates & Infrastructure | $ | 2,786 | $ | 2,951 | $ | 5,641 | $ | 5,959 | ||||||
| Coatings & Performance Monomers | $ | 864 | $ | 928 | $ | 1,709 | $ | 1,813 | ||||||
| Consumer Solutions | 1,265 | 1,315 | 2,491 | 2,582 | ||||||||||
| Performance Materials & Coatings | $ | 2,129 | $ | 2,243 | $ | 4,200 | $ | 4,395 | ||||||
| Corporate | $ | 164 | $ | 206 | $ | 359 | $ | 381 | ||||||
| Total | $ | 10,104 | $ | 10,915 | $ | 20,535 | $ | 21,680 |
| Net Trade Sales by Geographic Region | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| U.S. & Canada | $ | 3,988 | $ | 4,191 | $ | 8,215 | $ | 8,321 | ||||||
| EMEAI 1 | 3,272 | 3,572 | 6,546 | 7,056 | ||||||||||
| Asia Pacific | 1,737 | 1,901 | 3,595 | 3,822 | ||||||||||
| Latin America | 1,107 | 1,251 | 2,179 | 2,481 | ||||||||||
| Total | $ | 10,104 | $ | 10,915 | $ | 20,535 | $ | 21,680 |
1.Europe, Middle East, Africa and India.
Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.
Revenue recognized in the first six months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $130 million (approximately $90 million in the first six months of 2024). In the first six months of 2025 and 2024, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant.
The following table summarizes contract assets and liabilities at June 30, 2025 and December 31, 2024:
| Contract Assets and Liabilities | Balance Sheet Classification | Jun 30, 2025 | Dec 31, 2024 | ||||||||
| In millions | |||||||||||
| Accounts and notes receivable - trade | Accounts and notes receivable - trade | $ | 5,426 | $ | 4,756 | ||||||
| Contract assets - noncurrent | Deferred charges and other assets | $ | — | $ | 2 | ||||||
| Contract liabilities - current | Accrued and other current liabilities | $ | 196 | $ | 244 | ||||||
| Contract liabilities - noncurrent | Other noncurrent obligations | $ | 1,431 | $ | 1,480 |
NOTE 4 – DIVESTITURES
Divestiture of Soil Fumigation Product Line
On May 1, 2025, the Company sold TeloneTM, a soil fumigation product line, and certain related assets, to TriCal Soil Solutions, Inc. ("TriCal"), a distributor and applicator of soil fumigation products, for cash proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-closing adjustments. Under the sale and purchase agreement, Dow retained ownership of the related production assets, which are leased to TriCal as part of a toll manufacturing arrangement that directs the Company to manufacture and deliver certain products to TriCal. These asset leases are classified as operating leases. Dow and TriCal have also entered into a site services agreement related to certain services the Company will provide to TriCal at its site in Stade, Germany. Divested assets included property with a net book value of $5 million and goodwill of $10 million. The Company recognized a pretax gain of $103 million in the second quarter of 2025, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.
The Company evaluated the divestiture of its soil fumigation product line and determined the divestiture did not represent a strategic shift that had a major effect on the Company’s operations and financial results and did not qualify as an individually significant component of the Company. As a result, the divestiture is not reported as discontinued operations.
Divestiture of Investment in DowAksa
On June 2, 2025, the Company announced it entered into a definitive agreement to sell its ownership interest in DowAksa Advanced Composites Holdings BV ("DowAksa"), a nonconsolidated affiliate, to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for approximately $125 million. The Company is targeting to close the transaction in the third quarter of 2025, subject to regulatory approval and other closing conditions, and expects to record a gain on the transaction.
NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's 2023 Restructuring Program and other asset related charges, see Note 5 to the Consolidated Financial Statements included in the 2024 10-K.
2025 Restructuring Program
On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. The actions include a workforce reduction of approximately 1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate. These actions are expected to be substantially complete by the end of 2026.
On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other exit and disposal costs. As a result of these actions, in the second quarter of 2025 the Company recorded pretax restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 21 for additional information on nonrecurring fair value measurements. The following table summarizes the activities related to the 2025 Restructuring Program, including segment information:
| 2025 Restructuring Program | Severance and Related Benefit Costs | Asset Write-downs and Write-offs | Costs Associated with Exit and Disposal Activities | Total | ||||||||||
| In millions | ||||||||||||||
| Corporate | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Total restructuring charges | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Reserve balance at Mar 31, 2025 | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Packaging & Specialty Plastics | $ | — | $ | 81 | $ | 77 | $ | 158 | ||||||
| Industrial Intermediates & Infrastructure | — | 63 | 26 | 89 | ||||||||||
| Performance Materials & Coatings | — | 147 | — | 147 | ||||||||||
| Corporate | 154 | 43 | — | 197 | ||||||||||
| Total restructuring charges | $ | 154 | $ | 334 | $ | 103 | $ | 591 | ||||||
| Charges against the reserve 1 | — | (334) | (103) | (437) | ||||||||||
| Cash payments | (16) | — | — | (16) | ||||||||||
| Reserve balance at Jun 30, 2025 | $ | 345 | $ | — | $ | — | $ | 345 | ||||||
1.Costs associated with exit and disposal activities relate to asset retirement obligations.
At June 30, 2025, $178 million of the restructuring reserve balance was included in "Accrued and other current liabilities" and $167 million was included in "Other noncurrent obligations" in the consolidated balance sheets.
The Company recorded pretax restructuring charges of $798 million inception-to-date under the 2025 Restructuring Program, consisting of severance and related benefit costs of $361 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million.
Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions and costs associated with the Company's restructuring actions, are expected to result in additional cash expenditures of approximately $225 million. Restructuring implementation costs totaled $5 million for the three and six months ended June 30, 2025.
Severance and Related Benefit Costs
Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are accrued against the Corporate segment once management commits to a plan of termination. The 2025 Restructuring Program included charges for severance and related benefit costs of $361 million. At June 30, 2025, $16 million in severance payments had been made.
Asset Write-downs and Write-offs
The 2025 Restructuring Program included charges related to the write-down and write-off of assets totaling $334 million. Details regarding the asset write-downs and write-offs are as follows:
-
Packaging & Specialty Plastics recorded a charge to rationalize its global asset footprint by shutting down an ethylene facility in Böhlen, Germany by the end of 2027.
-
Industrial Intermediates & Infrastructure recorded a charge to primarily rationalize its global asset footprint by shutting down certain chlor-alkali and vinyl assets in Schkopau, Germany by the end of 2027.
-
Performance Materials & Coatings recorded a charge to primarily rationalize its global asset footprint by shutting down a basics siloxanes plant in Barry, United Kingdom by mid-year 2026.
-
Corporate recorded charges related to the write-down of certain Company owned and leased non-manufacturing facilities and other assets.
Costs Associated with Exit and Disposal Activities
The Company accrued additional asset retirement obligations of $111 million in the second quarter of 2025 associated with the asset shutdowns noted above, resulting in charges of $103 million after the impact of estimated recoveries. See Note 14 for additional information related to the Company’s asset retirement obligations. It is reasonably possible the Company will incur approximately $60 million of future charges related to costs associated with exit and disposal activities.
In addition, the Company is assessing potential environmental remediation activities associated with the asset actions noted above, which could result in additional charges and cash payments in the future. The Company intends to continue operating other assets at the sites impacted by these actions.
2023 Restructuring Program
Actions related to the restructuring program approved by the Board on January 25, 2023, were complete at the end of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Industrial Intermediates & Infrastructure. See Note 21 for additional information on nonrecurring fair value measurements. Restructuring implementation and efficiency costs were zero and $50 million for the three and six months ended June 30, 2025, respectively ($56 million and $102 million for the three and six months ended June 30, 2024, respectively).
NOTE 6 – SUPPLEMENTARY INFORMATION
| Dow Inc. Sundry Income (Expense) – Net | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Non-operating pension and other postretirement benefit plan net credits 1 | $ | 36 | $ | 61 | $ | 74 | $ | 122 | ||||||
| Foreign exchange gains (losses) 2 | 4 | (12) | 11 | (35) | ||||||||||
| Gain (loss) on sales of other assets and investments | (2) | 10 | (5) | 19 | ||||||||||
| Gain on divestiture of soil fumigation product line 3 | 103 | — | 103 | — | ||||||||||
| Gain (loss) on early extinguishment of debt 4 | — | 5 | (60) | 5 | ||||||||||
| Indemnification and other transaction related costs 5 | (17) | 1 | (17) | 1 | ||||||||||
| Other - net | 23 | 11 | 54 | 25 | ||||||||||
| Total sundry income (expense) – net | $ | 147 | $ | 76 | $ | 160 | $ | 137 |
1.See Note 18 for additional information.
2.Foreign exchange losses for the three months ended June 30, 2024 relate primarily to exposures in the Argentine peso, while losses in the six months ended June 30, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.
3.See Note 4 for additional information.
4.See Note 13 for additional information.
5.Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. and Corteva, Inc. as part of the separation and distribution.
Sundry income (expense) - net for TDCC for the three and six months ended June 30, 2025 and 2024 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.
Other Investments
The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:
| Investments in Company-Owned Life Insurance | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Gross cash value | $ | 535 | $ | 558 | ||||
| Less: Existing drawdowns 1 | 200 | — | ||||||
| Less: Accrued interest on drawdowns 2 | 3 | — | ||||||
| Investments in company-owned life insurance 3 | $ | 332 | $ | 558 |
1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.
2.Included in "Sundry income (expense) - net" in the consolidated statements of income.
3.Classified as "Other investments" in the consolidated balance sheets.
Supplier Finance Program
The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At June 30, 2025, outstanding obligations confirmed as valid under the SCF program were $306 million ($291 million at December 31, 2024), included in “Accounts payable – Trade” in the consolidated balance sheets.
NOTE 7 – INCOME TAXES
As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision for income taxes, the following income tax discussion does not include reference to TDCC's provision for income taxes or its effective tax rate.
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level.
In the second quarter of 2025, the Company reported a provision for income taxes of $142 million, resulting in a negative effective tax rate of 21.5 percent ($150 million in the second quarter of 2024, resulting in an effective tax rate of 24.7 percent). For the first six months of 2025, the Company reported a provision for income taxes of $58 million, resulting in a negative effective tax rate of 5.6 percent ($61 million for the first six months of 2024, resulting in an effective tax rate of 5.8 percent).
The provision for income taxes for the three and six months ended June 30, 2025 was unfavorably impacted by the recording of valuation allowances in certain foreign jurisdictions of $242 million as well as losses attributable to jurisdictions for which no tax benefit can be recognized, and a tax credit of $89 million related to the sale of a portion of the Company's membership interest in its wholly owned subsidiary, Diamond Infrastructure Solutions, resulting in a negative effective tax rate for both periods. See Note 17 for additional information related to the Diamond Infrastructure Solutions transaction. In the first quarter of 2024, the Company recorded a tax credit of $194 million related to a reassessment of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the first six months of 2024.
NOTE 8 – EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for Dow Inc. for the three and six months ended June 30, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.
| Net Income (Loss) for Earnings Per Share Calculations | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Net income (loss) | $ | (801) | $ | 458 | $ | (1,091) | $ | 996 | ||||||
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 | ||||||||||
| Net income attributable to participating securities 1 | 4 | 3 | 7 | 6 | ||||||||||
| Net income (loss) attributable to common stockholders | $ | (839) | $ | 436 | $ | (1,149) | $ | 949 |
1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.
| Earnings (Loss) Per Share - Basic and Diluted | Three Months Ended | Six Months Ended | ||||||||||||
| Dollars per share | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Earnings (loss) per common share - basic | $ | (1.18) | $ | 0.62 | $ | (1.62) | $ | 1.35 | ||||||
| Earnings (loss) per common share - diluted | $ | (1.18) | $ | 0.62 | $ | (1.62) | $ | 1.35 |
| Share Count Information | Three Months Ended | Six Months Ended | ||||||||||||
| Shares in millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Weighted-average common shares outstanding - basic | 709.5 | 703.8 | 708.2 | 704.1 | ||||||||||
| Plus dilutive effect of equity compensation plans 1 | — | 1.5 | — | 1.4 | ||||||||||
| Weighted-average common shares outstanding - diluted | 709.5 | 705.3 | 708.2 | 705.5 | ||||||||||
| Stock units excluded from EPS calculations 2 | 19.6 | 9.4 | 17.2 | 9.1 |
1.The three and six months ended June 30, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
NOTE 9 – INVENTORIES
The following table provides a breakdown of inventories:
| Inventories | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Finished goods | $ | 3,764 | $ | 3,773 | ||||
| Work in process | 1,365 | 1,323 | ||||||
| Raw materials | 845 | 822 | ||||||
| Supplies | 1,137 | 1,039 | ||||||
| Total | $ | 7,111 | $ | 6,957 | ||||
| Adjustment of inventories to the LIFO basis | (410) | (413) | ||||||
| Total inventories | $ | 6,701 | $ | 6,544 |
NOTE 10 – NONCONSOLIDATED AFFILIATES
For additional information on the Company’s nonconsolidated affiliates, see Note 11 to the Consolidated Financial Statements included in the 2024 10-K.
The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets are shown in the following table:
| Investments in Nonconsolidated Affiliates | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Investment in nonconsolidated affiliates | $ | 1,262 | $ | 1,266 | ||||
| Other noncurrent obligations | (792) | (568) | ||||||
| Net investment in nonconsolidated affiliates | $ | 470 | $ | 698 |
At June 30, 2025, the Company had a negative investment balance in Sadara Chemical Company of $717 million included in "Other noncurrent obligations" (negative $517 million at December 31, 2024) in the consolidated balance sheets. The increased negative investment in Sadara Chemical Company at June 30, 2025 is due to equity losses generated during the first six months of 2025 driven by the impact of challenging macroeconomic conditions.
At June 30, 2025, the Company had a negative investment balance in EQUATE Petrochemical Company K.S.C.C of $75 million included in "Other noncurrent obligations" (negative $51 million at December 31, 2024) in the consolidated balance sheets. The increase in the negative investment was driven by dividends distributed to shareholders, partially offset by equity earnings in the first six months of 2025.
NOTE 11 – GOODWILL
The following table shows changes in the carrying amount of goodwill by reportable segment:
| Goodwill | Packaging & Specialty Plastics | Industrial Intermediates & Infrastructure | Performance Materials & Coatings | Total | ||||||||||
| In millions | ||||||||||||||
| Net goodwill at Dec 31, 2024 | $ | 5,118 | $ | 1,092 | $ | 2,355 | $ | 8,565 | ||||||
| Divestiture | — | (10) | — | (10) | ||||||||||
| Foreign currency impact | 12 | 5 | 126 | 143 | ||||||||||
| Net goodwill at Jun 30, 2025 | $ | 5,130 | $ | 1,087 | $ | 2,481 | $ | 8,698 |
Goodwill Impairment Testing
During the second quarter of 2025, the Company identified potential indicators of goodwill impairment due to announced restructuring actions and ongoing macroeconomic challenges. As a result, the Company evaluated whether the fair value of any reporting unit may be less than its carrying amount. This assessment indicated that the Consumer Solutions reporting unit, part of the Performance Materials & Coatings segment, required an interim quantitative goodwill impairment test as of June 30, 2025. The test concluded that no goodwill impairment existed, as the fair value of the Consumer Solutions reporting unit exceeded its carrying value. Fair value was estimated using a discounted cash flow model that incorporated current market conditions and the anticipated effects of the restructuring actions. Key assumptions included projected revenue growth, discount rate, tax rate, terminal value, currency exchange rates, and long-term raw material and energy price forecasts.
NOTE 12 – TRANSFERS OF FINANCIAL ASSETS
Accounts Receivable Programs
The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three and six months ended June 30, 2025 and 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 14 for additional information related to guarantees.
The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three and six months ended June 30, 2025 and 2024.
The following table provides a summary of cash flows related to the Programs and the Facilities for the three and six months ended June 30, 2025 and 2024:
| Cash Flows Related to Transfers of Accounts Receivable | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Proceeds received from new transfers | $ | 24 | $ | 623 | $ | 538 | $ | 1,050 | ||||||
The following table provides the balances related to the Programs and the Facilities at June 30, 2025 and December 31, 2024:
| Balances Related to Transfers of Accounts Receivable | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Balance outstanding | $ | 34 | $ | 287 | ||||
| Accounts receivable derecognized | $ | 5 | $ | 278 | ||||
| Amounts recognized in the consolidated balance sheets: | ||||||||
| Accrued and other current liabilities 1 | $ | 29 | $ | 9 |
- Represents amounts collected from customers and not yet remitted by the Company.
NOTE 13 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
| Notes Payable | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Notes payable to banks and other lenders | $ | 149 | $ | 135 | ||||
| Period-end average interest rates | 28.81 | % | 36.03 | % |
| Long-Term Debt | 2025 Average Rate | Jun 30, 2025 | 2024 Average Rate | Dec 31, 2024 | |||||||||||||
| In millions | |||||||||||||||||
| Promissory notes and debentures: | |||||||||||||||||
| Final maturity 2025 | 4.55 | % | $ | 208 | 5.63 | % | $ | 333 | |||||||||
| Final maturity 2028 | 4.80 | % | 600 | 4.80 | % | 600 | |||||||||||
| Final maturity 2029 1 | 7.53 | % | 951 | 7.58 | % | 1,368 | |||||||||||
| Final maturity 2030 | 2.10 | % | 818 | 2.10 | % | 818 | |||||||||||
| Final maturity 2031 and thereafter 1 | 5.41 | % | 10,223 | 5.37 | % | 9,192 | |||||||||||
| Other facilities: | |||||||||||||||||
| Foreign currency notes and loans, various rates and maturities 1 | 2.11 | % | 2,250 | 2.01 | % | 2,540 | |||||||||||
| InterNotes®, varying maturities through 2053 | 4.53 | % | 756 | 4.31 | % | 661 | |||||||||||
| Medium-term notes, maturity 2025 | 4.75 | % | 1 | 4.75 | % | 1 | |||||||||||
| Finance lease obligations 2 | 1,066 | 939 | |||||||||||||||
| Unamortized debt discount and issuance costs | (225) | (244) | |||||||||||||||
| Long-term debt due within one year 3 | (401) | (497) | |||||||||||||||
| Long-term debt | $ | 16,247 | $ | 15,711 |
1.Cost includes net fair value hedge adjustment gains of $43 million at June 30, 2025 ($9 million at December 31, 2024). See Note 20 for additional information.
2.See Note 15 for additional information.
3.Presented net of current portion of unamortized debt issuance costs.
| Maturities of Long-Term Debt for Next Five Years at Jun 30, 2025 | |||||
| In millions | |||||
| 2025 | $ | 317 | |||
| 2026 | $ | 152 | |||
| 2027 | $ | 771 | |||
| 2028 | $ | 742 | |||
| 2029 | $ | 1,054 | |||
| 2030 | $ | 953 |
2025 Activity
In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.
In the first six months of 2025, the Company issued an aggregate principal amount of $107 million of InterNotes®. Additionally, the Company repaid $125 million of long-term debt at maturity.
Available Credit Facilities
The following table summarizes the Company's credit facilities:
| Committed and Available Credit Facilities at Jun 30, 2025 | ||||||||||||||
| In millions | Committed Credit | Available Credit | Maturity Date | Interest | ||||||||||
| Five Year Competitive Advance and Revolving Credit Facility | $ | 5,000 | $ | 5,000 | June 2030 | Floating rate | ||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | September 2025 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 175 | 175 | September 2025 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 300 | 300 | November 2025 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 300 | 300 | February 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | March 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 375 | 375 | October 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 150 | 150 | November 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | November 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 250 | 250 | March 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | May 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 350 | 350 | June 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | September 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | October 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | November 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 300 | 300 | May 2028 | Floating rate | ||||||||||
| Total committed and available credit facilities | $ | 8,400 | $ | 8,400 |
Debt Covenants and Default Provisions
There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first six months of 2025. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.
NOTE 14 – COMMITMENTS AND CONTINGENCIES
A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2024 10-K, which is incorporated by reference herein.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At June 30, 2025, the Company had accrued obligations of $1,071 million for probable environmental remediation and restoration costs ($1,113 million at December 31, 2024), including $224 million for the remediation of Superfund sites ($234 million at December 31, 2024). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.
Litigation
Asbestos-Related Matters of Union Carbide Corporation
Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined that no adjustment to the accrual was required at June 30, 2025.
Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $745 million at June 30, 2025 ($791 million at December 31, 2024). At June 30, 2025, approximately 26 percent of the recorded claim liability related to pending claims and approximately 74 percent related to future claims.
Legacy Matters
Groundwater Matters
The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). The costs associated with these Groundwater Matters were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of certain Groundwater Matters related to wells deemed to be probable and estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims and accrued a charge based on the estimate. In the second quarter of 2025, the Company completed a reassessment study of these Groundwater Matters based on current known factors, resulting in a reduced estimate of the cost of pending and future claims. As a result, the Company recorded a pretax credit of $106 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate. In the second quarter of 2025, the Company settled a separate claim related to Groundwater Matters at a water storage district, resulting in a pretax charge of $64 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate.
At June 30, 2025, the total liability related to settled claims and the probable and estimable settlement of all alleged Groundwater Matters was $99 million ($155 million at December 31, 2024), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.
The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at June 30, 2025.
Other Legacy Matters
On October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11, 2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025, which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and was paid in the second quarter of 2025.
Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter
In 2019, The Court of King's Bench of Alberta, Canada ("Court") signed a judgment ordering Nova Chemicals Corporation ("Nova") to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) for damages the Company incurred through 2012 related to the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada, for which the Company received payment in October 2019 and March 2020. At June 30, 2025, $201 million ($201 million at December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.
On June 10, 2025, the Court signed a separate judgment ordering Nova to pay the Company an additional amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages the Company incurred through June 2018, which had not been previously quantified. The Court again found that Nova failed to operate the companies' jointly-owned ethylene asset at full capacity during this time and, furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production, depriving the Company of millions of pounds of ethylene. The award includes interest to April 7, 2025, but excludes subsequent interest and legal costs. While the judgment is subject to appeal, payment of the judgment is required and Dow expects to receive the additional cash proceeds by the end of 2025.
Guarantees
The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:
| Guarantees | Jun 30, 2025 | Dec 31, 2024 | ||||||||||||||||||
| In millions | Final Expiration | Maximum Future Payments | Recorded Liability | Final Expiration | Maximum Future Payments | Recorded Liability | ||||||||||||||
| Guarantees | 2038 | $ | 1,229 | $ | 144 | 2038 | $ | 1,456 | $ | 155 |
Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.
The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is $5 million at June 30, 2025 ($239 million at December 31, 2024). The Company expects receivable collections and remittances to occur within the next six months.
TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. The Company does not expect to be required to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.
Asset Retirement Obligations
Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets; and retirement obligations are typically realized only upon demolition of those facilities. As a result of the asset shutdowns included in the restructuring activities discussed in Note 5, the Company accrued additional asset retirement obligations of $111 million in the second quarter of 2025. At June 30, 2025, the aggregate carrying amount of the Company's asset retirement obligations was $300 million ($174 million at December 31, 2024), which was included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.
NOTE 15 – LEASES
For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2024 10-K.
The components of lease cost for operating and finance leases for the three and six months ended June 30, 2025 and 2024 were as follows:
| Lease Cost | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Operating lease cost | $ | 109 | $ | 110 | $ | 215 | $ | 217 | ||||||
| Finance lease cost | ||||||||||||||
| Amortization of right-of-use assets - finance | 32 | 28 | 64 | 55 | ||||||||||
| Interest on lease liabilities - finance | 12 | 12 | 24 | 22 | ||||||||||
| Total finance lease cost | 44 | 40 | 88 | 77 | ||||||||||
| Short-term lease cost | 87 | 88 | 167 | 162 | ||||||||||
| Variable lease cost | 283 | 265 | 538 | 523 | ||||||||||
| Sublease income | (1) | (3) | (3) | (5) | ||||||||||
| Total lease cost | $ | 522 | $ | 500 | $ | 1,005 | $ | 974 |
The following table provides supplemental cash flow and other information related to leases:
| Other Lease Information | Six Months Ended | |||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | ||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||
| Operating cash flows for operating leases | $ | 222 | $ | 223 | ||||
| Operating cash flows for finance leases | $ | 24 | $ | 22 | ||||
| Financing cash flows for finance leases | $ | 54 | $ | 61 | ||||
| Right-of-use assets obtained in exchange for lease obligations: | ||||||||
| Operating leases | $ | 108 | $ | 119 | ||||
| Finance leases | $ | 165 | $ | 168 |
NOTE 16 – ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and six months ended June 30, 2025 and 2024 were as follows:
| Accumulated Other Comprehensive Loss | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Unrealized Gains (Losses) on Investments | ||||||||||||||
| Beginning balance | $ | (211) | $ | (259) | $ | (243) | $ | (253) | ||||||
| Unrealized gains (losses) on investments | (25) | 65 | 15 | 80 | ||||||||||
| Tax (expense) benefit | 2 | (2) | (5) | (20) | ||||||||||
| Net unrealized gains (losses) on investments | (23) | 63 | 10 | 60 | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 1 | 1 | (3) | — | (7) | ||||||||||
| Tax expense (benefit) 2 | — | 1 | — | 2 | ||||||||||
| Net (gains) losses reclassified from AOCL to net income (loss) | 1 | (2) | — | (5) | ||||||||||
| Other comprehensive income (loss), net of tax | (22) | 61 | 10 | 55 | ||||||||||
| Ending balance | $ | (233) | $ | (198) | $ | (233) | $ | (198) | ||||||
| Cumulative Translation Adjustments | ||||||||||||||
| Beginning balance | $ | (1,941) | $ | (2,013) | $ | (2,063) | $ | (1,891) | ||||||
| Gains (losses) on foreign currency translation | 129 | (39) | 255 | (155) | ||||||||||
| Tax (expense) benefit | 12 | — | 15 | (3) | ||||||||||
| Net gains (losses) on foreign currency translation | 141 | (39) | 270 | (158) | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 3 | (12) | (4) | (19) | (7) | ||||||||||
| Other comprehensive income (loss), net of tax | 129 | (43) | 251 | (165) | ||||||||||
| Ending balance | $ | (1,812) | $ | (2,056) | $ | (1,812) | $ | (2,056) | ||||||
| Pension and Other Postretirement Benefit Plans | ||||||||||||||
| Beginning balance | $ | (5,700) | $ | (5,469) | $ | (5,720) | $ | (5,486) | ||||||
| Gains (losses) arising during the period | 1 | 1 | 1 | — | ||||||||||
| Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 4 | 26 | 21 | 52 | 43 | ||||||||||
| Tax expense (benefit) 2 | (6) | (5) | (12) | (9) | ||||||||||
| Net loss and prior service credits reclassified from AOCL to net income (loss) | 20 | 16 | 40 | 34 | ||||||||||
| Other comprehensive income (loss), net of tax | 21 | 17 | 41 | 34 | ||||||||||
| Ending balance | $ | (5,679) | $ | (5,452) | $ | (5,679) | $ | (5,452) | ||||||
| Derivative Instruments | ||||||||||||||
| Beginning balance | $ | (104) | $ | (73) | $ | (84) | $ | (51) | ||||||
| Gains (losses) on derivative instruments | 6 | (13) | (9) | (46) | ||||||||||
| Tax (expense) benefit | (4) | 8 | (6) | 11 | ||||||||||
| Net gains (losses) on derivative instruments | 2 | (5) | (15) | (35) | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 5 | 1 | (1) | (3) | 9 | ||||||||||
| Tax expense (benefit) 2 | (1) | — | — | (2) | ||||||||||
| Net (gains) losses reclassified from AOCL to net income (loss) | — | (1) | (3) | 7 | ||||||||||
| Other comprehensive income (loss), net of tax | 2 | (6) | (18) | (28) | ||||||||||
| Ending balance | $ | (102) | $ | (79) | $ | (102) | $ | (79) | ||||||
| Total AOCL ending balance | $ | (7,826) | $ | (7,785) | $ | (7,826) | $ | (7,785) |
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Provision for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
NOTE 17 – NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.
On May 1, 2025, TDCC sold 40 percent of the membership interests of its wholly owned subsidiary, Diamond Infrastructure Solutions, a dedicated infrastructure company, to InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset Management, a global infrastructure and energy asset manager, in exchange for cash proceeds of approximately $2.4 billion, included in "Proceeds from sale of noncontrolling interests" in the consolidated statements of cash flows. Under the terms of the sale and purchase agreement, InfraPark has the option to purchase up to an additional 9 percent of Diamond Infrastructure Solutions' membership interests within six months of the closing date of the sale in exchange for additional cash proceeds of up to $600 million. Diamond Infrastructure Solutions and its subsidiaries own and operate certain non-product producing energy, environmental, pipeline and other related infrastructure assets located at five of the Company's manufacturing sites on the U.S. Gulf Coast and provides infrastructure services to Dow manufacturing assets and other third-party tenants at these locations. InfraPark's ownership is accounted for as a noncontrolling interest in Diamond Infrastructure Solutions. The transaction resulted in an increase in "Additional paid-in capital" of $1,540 million, recorded in the consolidated balance sheets and the consolidated statements of equity, and an increase in "Noncontrolling interests" of $834 million, recorded in the consolidated balance sheets.
The following table summarizes the activity for equity attributable to noncontrolling interests for the three and six months ended June 30, 2025 and 2024:
| Noncontrolling Interests | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Balance at beginning of period | $ | 507 | $ | 492 | $ | 496 | $ | 501 | ||||||
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 | ||||||||||
| Distributions to noncontrolling interests 1 | (26) | (25) | (48) | (39) | ||||||||||
| Cumulative translation adjustments | 12 | (4) | 28 | (20) | ||||||||||
| Sale of noncontrolling interests | 834 | — | 834 | — | ||||||||||
| Other | — | — | — | (1) | ||||||||||
| Balance at end of period | $ | 1,361 | $ | 482 | $ | 1,361 | $ | 482 |
- Includes dividends paid to a joint venture of $8 million for the three and six months ended June 30, 2025 ($8 million for the three and six months ended June 30, 2024) which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income.
NOTE 18 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:
| Net Periodic Benefit Cost (Credit) for All Significant Plans | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Defined Benefit Pension Plans | ||||||||||||||
| Service cost | $ | 11 | $ | 14 | $ | 21 | $ | 28 | ||||||
| Interest cost | 249 | 250 | 495 | 502 | ||||||||||
| Expected return on plan assets | (322) | (343) | (641) | (689) | ||||||||||
| Amortization of prior service credit | (3) | (4) | (6) | (7) | ||||||||||
| Amortization of net loss | 41 | 36 | 81 | 71 | ||||||||||
| Net periodic benefit credit | $ | (24) | $ | (47) | $ | (50) | $ | (95) | ||||||
| Other Postretirement Benefit Plans | ||||||||||||||
| Service cost | $ | 1 | $ | 1 | $ | 2 | $ | 2 | ||||||
| Interest cost | 11 | 11 | 20 | 22 | ||||||||||
| Amortization of net gain | (12) | (11) | (23) | (21) | ||||||||||
| Net periodic benefit cost (credit) | $ | — | $ | 1 | $ | (1) | $ | 3 |
Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.
NOTE 19 – STOCK-BASED COMPENSATION
A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2024 10-K.
Stock Incentive Plan
The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.
In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:
-
1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-average fair value of $8.27 per share;
-
3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and
-
2.1 million performance stock units with a weighted-average fair value of $38.46 per share.
There was minimal grant activity in the second quarter of 2025.
Employee Stock Purchase Plan
The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025 (ending) of the offering period, whichever is lower.
In the first quarter of 2025, employees subscribed to the right to purchase approximately 3.2 million shares under the 2021 ESPP. In the second quarter of 2025, due to the change in the Company's stock price, employees now have the right to purchase approximately 3.9 million shares. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2025. The shares will be delivered to employees in the fourth quarter of 2025.
NOTE 20 – FINANCIAL INSTRUMENTS
A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.
Refer to Note 21 for a summary of the fair value of financial instruments at June 30, 2025 and December 31, 2024.
Debt Securities
The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the six months ended June 30, 2025 and 2024:
| Investing Results | Six Months Ended | |||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | ||||||
| Proceeds from sales of available-for-sale securities | $ | 220 | $ | 1,291 | ||||
| Gross realized gains | $ | 5 | $ | 19 | ||||
| Gross realized losses | $ | (5) | $ | (12) |
The following table summarizes contractual maturities of the Company's investments in debt securities:
| Contractual Maturities of Debt Securities at Jun 30, 2025 | Cost | Fair Value | ||||||
| In millions | ||||||||
| Within one year | $ | 120 | $ | 113 | ||||
| One to five years | 1,151 | 1,058 | ||||||
| Six to ten years | 407 | 403 | ||||||
| After ten years | 544 | 447 | ||||||
| Total | $ | 2,222 | $ | 2,021 |
Equity Securities
There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three and six months ended June 30, 2025. There was $1 million of net unrealized gains recognized in earnings on equity securities for the three months ended June 30, 2025 (no unrealized gains or losses for the three months ended June 30, 2024). There was $2 million of net unrealized losses recognized in earnings on equity securities for the six months ended June 30, 2025 (no unrealized gains or losses for the six months ended June 30, 2024).
| Investments in Equity Securities | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Readily determinable fair value | $ | 12 | $ | 14 | ||||
| Not readily determinable fair value | $ | 145 | $ | 153 |
Derivative Instruments
The notional amounts of the Company's derivative instruments at June 30, 2025 and December 31, 2024 were as follows:
| Notional Amounts 1 | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Derivatives designated as hedging instruments: | ||||||||
| Interest rate contracts | $ | 2,572 | $ | 1,870 | ||||
| Foreign currency contracts | $ | 6,148 | $ | 3,144 | ||||
| Derivatives not designated as hedging instruments: | ||||||||
| Interest rate contracts | $ | 884 | $ | 14 | ||||
| Foreign currency contracts | $ | 20,332 | $ | 9,244 |
1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.
The notional amounts of the Company's commodity derivatives at June 30, 2025 and December 31, 2024 were as follows:
| Commodity Notionals 1 | Jun 30, 2025 | Dec 31, 2024 | Notional Volume Unit | ||||||||
| Derivatives designated as hedging instruments: | |||||||||||
| Hydrocarbon derivatives | 4.7 | 3.2 | million barrels of oil equivalent | ||||||||
| Derivatives not designated as hedging instruments: | |||||||||||
| Hydrocarbon derivatives | 0.8 | 1.1 | million barrels of oil equivalent | ||||||||
1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
| Maximum Maturity Dates of Derivatives Designated as Hedging Instruments | Year | ||||
| Interest rate contracts | 2027 | ||||
| Foreign currency contracts | 2026 | ||||
| Commodity contracts | 2028 |
The following table provides the fair value and balance sheet classification of derivative instruments at June 30, 2025 and December 31, 2024:
| Fair Value of Derivative Instruments | Jun 30, 2025 | Dec 31, 2024 | |||||||||||||||||||||
| In millions | Gross | Counterparty and Cash Collateral Netting 1 | Net 2 | Gross | Counterparty and Cash Collateral Netting 1 | Net 2 | |||||||||||||||||
| Asset derivatives | |||||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 3 | $ | 99 | $ | (68) | $ | 31 | $ | 20 | $ | (20) | $ | — | |||||||||||
| Interest rate contracts 4 | 20 | (16) | 4 | — | — | — | |||||||||||||||||
| Foreign currency contracts 3 | 57 | (56) | 1 | 33 | (15) | 18 | |||||||||||||||||
| Foreign currency contracts 4 | 1 | (1) | — | — | — | — | |||||||||||||||||
| Commodity contracts 3 | 136 | (110) | 26 | 25 | (14) | 11 | |||||||||||||||||
| Commodity contracts 4 | 108 | (95) | 13 | 46 | (36) | 10 | |||||||||||||||||
| Total | $ | 421 | $ | (346) | $ | 75 | $ | 124 | $ | (85) | $ | 39 | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 3 | $ | 5 | $ | (4) | $ | 1 | $ | — | $ | — | $ | — | |||||||||||
| Interest rate contracts 4 | 1 | (1) | — | — | — | — | |||||||||||||||||
| Foreign currency contracts 3 | 93 | (83) | 10 | 74 | (16) | 58 | |||||||||||||||||
| Commodity contracts 3 | 31 | (14) | 17 | 16 | (1) | 15 | |||||||||||||||||
| Commodity contracts 4 | 5 | (4) | 1 | 4 | (3) | 1 | |||||||||||||||||
| Total | $ | 135 | $ | (106) | $ | 29 | $ | 94 | $ | (20) | $ | 74 | |||||||||||
| Total asset derivatives | $ | 556 | $ | (452) | $ | 104 | $ | 218 | $ | (105) | $ | 113 | |||||||||||
| Liability derivatives | |||||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 5 | $ | 70 | $ | (68) | $ | 2 | $ | 46 | $ | (20) | $ | 26 | |||||||||||
| Interest rate contracts 6 | 16 | (16) | — | — | — | — | |||||||||||||||||
| Foreign currency contracts 5 | 155 | (56) | 99 | 75 | (15) | 60 | |||||||||||||||||
| Foreign currency contracts 6 | 1 | (1) | — | 40 | — | 40 | |||||||||||||||||
| Commodity contracts 5 | 139 | (113) | 26 | 16 | (14) | 2 | |||||||||||||||||
| Commodity contracts 6 | 103 | (96) | 7 | 37 | (36) | 1 | |||||||||||||||||
| Total | $ | 484 | $ | (350) | $ | 134 | $ | 214 | $ | (85) | $ | 129 | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 5 | $ | 4 | $ | (4) | $ | — | $ | 1 | $ | — | $ | 1 | |||||||||||
| Interest rate contracts 6 | 1 | (1) | — | — | — | — | |||||||||||||||||
| Foreign currency contracts 5 | 183 | (83) | 100 | 27 | (16) | 11 | |||||||||||||||||
| Commodity contracts 5 | 33 | (18) | 15 | 8 | (1) | 7 | |||||||||||||||||
| Commodity contracts 6 | 5 | (4) | 1 | 4 | (3) | 1 | |||||||||||||||||
| Total | $ | 226 | $ | (110) | $ | 116 | $ | 40 | $ | (20) | $ | 20 | |||||||||||
| Total liability derivatives | $ | 710 | $ | (460) | $ | 250 | $ | 254 | $ | (105) | $ | 149 |
1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
2.Represents the net amounts included in the consolidated balance sheets.
3.Included in "Other current assets" in the consolidated balance sheets.
4.Included in "Deferred charges and other assets" in the consolidated balance sheets.
5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6.Included in "Other noncurrent obligations" in the consolidated balance sheets.
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash
collateral of $15 million at June 30, 2025 ($16 million at December 31, 2024). No cash collateral was posted by counterparties with the Company at June 30, 2025 and December 31, 2024.
The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and six months ended June 30, 2025 and 2024:
| Effect of Derivative Instruments | Gain (loss) recognized in OCI 1 | Gain (loss) recognized in income 2 | |||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | |||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||
| Fair value hedges: | |||||||||||||||||||||||||||||
| Interest rate contracts 3, 4 | $ | — | $ | — | $ | — | $ | — | $ | 13 | $ | (23) | $ | 33 | $ | (23) | |||||||||||||
| Excluded components 3, 5 | 4 | (4) | (1) | (42) | — | — | — | — | |||||||||||||||||||||
| Cash flow hedges: | |||||||||||||||||||||||||||||
| Interest rate contracts 3 | (1) | — | — | 1 | — | (7) | (1) | (9) | |||||||||||||||||||||
| Foreign currency contracts 6 | 36 | (8) | 30 | (21) | 3 | 4 | 5 | 5 | |||||||||||||||||||||
| Foreign currency contracts 7 | (15) | — | (15) | — | — | — | — | — | |||||||||||||||||||||
| Commodity contracts 6 | (17) | 7 | (11) | 22 | (5) | 7 | (1) | (1) | |||||||||||||||||||||
| Excluded components 5, 6 | — | — | — | (6) | (2) | (3) | (3) | (4) | |||||||||||||||||||||
| Excluded components 7 | 7 | — | 7 | — | 3 | — | 3 | — | |||||||||||||||||||||
| Net foreign investment hedges: | |||||||||||||||||||||||||||||
| Foreign currency contracts | (55) | 6 | (82) | 8 | — | — | — | — | |||||||||||||||||||||
| Excluded components 5, 7 | 4 | 4 | 31 | 10 | 12 | 4 | 19 | 7 | |||||||||||||||||||||
| Total derivatives designated as hedging instruments | $ | (37) | $ | 5 | $ | (41) | $ | (28) | $ | 24 | $ | (18) | $ | 55 | $ | (25) | |||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||
| Interest rate contracts 3 | $ | — | $ | — | $ | — | $ | — | $ | 2 | $ | 1 | $ | 2 | $ | 1 | |||||||||||||
| Foreign currency contracts 7 | — | — | — | — | (156) | 29 | (212) | 60 | |||||||||||||||||||||
| Commodity contracts 6 | — | — | — | — | (12) | (6) | (17) | 2 | |||||||||||||||||||||
| Total return swap 6 | — | — | — | — | 35 | 4 | 24 | 26 | |||||||||||||||||||||
| Total derivatives not designated as hedging instruments | $ | — | $ | — | $ | — | $ | — | $ | (131) | $ | 28 | $ | (203) | $ | 89 | |||||||||||||
| Total derivatives | $ | (37) | $ | 5 | $ | (41) | $ | (28) | $ | (107) | $ | 10 | $ | (148) | $ | 64 |
1.OCI is defined as other comprehensive income (loss).
2.Pretax amounts.
3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
5.The excluded components are related to the time value of the derivatives designated as hedges.
6.Included in "Cost of sales" in the consolidated statements of income.
7.Included in "Sundry income (expense) - net" in the consolidated statements of income.
The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:
| Expected Reclassifications from AOCL within the next 12 months | Jun 30, 2025 | ||||
| In millions | |||||
| Cash flow hedges: | |||||
| Interest rate contracts | $ | (3) | |||
| Commodity contracts | $ | (3) | |||
| Foreign currency contracts | $ | (21) | |||
| Excluded components | $ | 2 | |||
| Net foreign investment hedges: | |||||
| Excluded components | $ | 23 |
NOTE 21 – FAIR VALUE MEASUREMENTS
A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2024 10-K.
Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:
| Fair Value Measurements on a Recurring Basis | Jun 30, 2025 | Dec 31, 2024 | ||||||||||||||||||||||||||||||
| In millions | Fair Value Level | Cost | Gain | Loss | Fair Value | Cost | Gain | Loss | Fair Value | |||||||||||||||||||||||
| Assets at fair value: | ||||||||||||||||||||||||||||||||
| Cash equivalents: | ||||||||||||||||||||||||||||||||
| Held-to-maturity securities 1 | Level 2 | $ | 234 | $ | — | $ | — | $ | 234 | $ | 96 | $ | — | $ | — | $ | 96 | |||||||||||||||
| Money market funds | Level 2 | 841 | — | — | 841 | 1,164 | — | — | 1,164 | |||||||||||||||||||||||
| Marketable securities 2 | Level 2 | 393 | — | (87) | 306 | 453 | — | (70) | 383 | |||||||||||||||||||||||
| Other investments: | ||||||||||||||||||||||||||||||||
| Debt securities: 3 | ||||||||||||||||||||||||||||||||
| Government debt 4 | Level 2 | 1,132 | 14 | (106) | 1,040 | 1,103 | 13 | (123) | 993 | |||||||||||||||||||||||
| Corporate bonds | Level 1 | 17 | — | (1) | 16 | 18 | — | (1) | 17 | |||||||||||||||||||||||
| Corporate bonds | Level 2 | 873 | 9 | (69) | 813 | 954 | 6 | (88) | 872 | |||||||||||||||||||||||
| Corporate bonds | Level 3 | 200 | — | (48) | 152 | 200 | — | (49) | 151 | |||||||||||||||||||||||
| Equity securities 3, 5 | Level 1 | 4 | 8 | — | 12 | 4 | 10 | — | 14 | |||||||||||||||||||||||
| Derivatives relating to: 6 | ||||||||||||||||||||||||||||||||
| Interest rates | Level 2 | — | 125 | — | 125 | — | 20 | — | 20 | |||||||||||||||||||||||
| Foreign currency | Level 2 | — | 151 | — | 151 | — | 107 | — | 107 | |||||||||||||||||||||||
| Commodities | Level 1 | — | 15 | — | 15 | — | 4 | — | 4 | |||||||||||||||||||||||
| Commodities | Level 2 | — | 265 | — | 265 | — | 87 | — | 87 | |||||||||||||||||||||||
| Total assets at fair value | $ | 3,970 | $ | 3,908 | ||||||||||||||||||||||||||||
| Liabilities at fair value: | ||||||||||||||||||||||||||||||||
| Long-term debt including debt due within one year 7 | Level 2 | $ | (16,648) | $ | 1,543 | $ | (435) | $ | (15,540) | $ | (16,208) | $ | 1,487 | $ | (484) | $ | (15,205) | |||||||||||||||
| Guarantee liability 8 | Level 3 | (144) | (155) | |||||||||||||||||||||||||||||
| Derivatives relating to: 6 | ||||||||||||||||||||||||||||||||
| Interest rates | Level 2 | — | — | (91) | (91) | — | — | (47) | (47) | |||||||||||||||||||||||
| Foreign currency | Level 2 | — | — | (339) | (339) | — | — | (142) | (142) | |||||||||||||||||||||||
| Commodities | Level 1 | — | — | (17) | (17) | — | — | (1) | (1) | |||||||||||||||||||||||
| Commodities | Level 2 | — | — | (263) | (263) | — | — | (64) | (64) | |||||||||||||||||||||||
| Total liabilities at fair value | $ | (16,394) | $ | (15,614) |
1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At June 30, 2025, $216 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $18 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.
2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
5.Equity securities with a readily determinable fair value.
6.See Note 20 for classification of derivatives in the consolidated balance sheets.
7.Cost includes fair value hedge adjustment gains of $43 million at June 30, 2025 and $9 million at December 31, 2024 on $5,538 million of debt at June 30, 2025 and $5,129 million at December 31, 2024.
8.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.
Cost approximates fair value for all other financial instruments.
For equity securities calculated at net asset value per share (or its equivalent), the Company had $83 million in private market securities and $14 million in real estate at June 30, 2025 ($90 million in private market securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the unfunded commitments on these investments were $79 million at June 30, 2025 and $81 million at December 31, 2024.
For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.
For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.
Fair Value Measurements on a Nonrecurring Basis
2025 Restructuring Program
In the second quarter of 2025, the Company recorded a charge for asset write-downs and write-offs, including the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other miscellaneous assets. The manufacturing facilities, corporate assets and certain leased, non-manufacturing facilities and other miscellaneous assets associated with this plan were written down to zero. In addition, impairments of certain leased, non-manufacturing facilities and other miscellaneous assets, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $110 million using unobservable inputs. The Company recorded impairment charges of $334 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($81 million), Industrial Intermediates & Infrastructure ($63 million), Performance Materials & Coatings ($147 million) and Corporate ($43 million).
2023 Restructuring Program
In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.
NOTE 22 – VARIABLE INTEREST ENTITIES
A summary of the Company's variable interest entities ("VIEs") not discussed below can be found in Note 23 to the Consolidated Financial Statements included in the 2024 10-K.
Assets and Liabilities of Consolidated VIEs
The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are included in “Net income attributable to noncontrolling interests” in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.
Infrastructure Entity
The Company has variable interests in Diamond Infrastructure Solutions, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S Gulf Coast as discussed in Note 17. The Company's variable interests relate to its membership interest and the service contracts between Diamond Infrastructure Solutions and Dow, under which a majority of the infrastructure services are provided to Dow using pass-through and cost-plus pricing. Diamond Infrastructure Solutions became a variable interest entity effective with the noncontrolling interest transaction on May 1, 2025. Dow is deemed the primary beneficiary as a result of decision rights held as the majority member.
The following table summarizes the carrying amounts of Diamond Infrastructure Solutions' assets and liabilities included in the Company’s consolidated balance sheets at June 30, 2025. Amounts presented are adjusted for intercompany eliminations.
| Assets and Liabilities of Diamond Infrastructure Solutions | Jun 30, 2025 | |||||||
| In millions | ||||||||
| Other current assets | $ | 163 | ||||||
| Net property | 2,259 | |||||||
| Other noncurrent assets | 196 | |||||||
| Total assets 1 | $ | 2,618 | ||||||
| Current liabilities | $ | 338 | ||||||
| Long-term debt | 176 | |||||||
| Other noncurrent obligations | 316 | |||||||
| Total liabilities 2 | $ | 830 |
1.All assets were restricted at June 30, 2025.
2.All liabilities were nonrecourse at June 30, 2025.
In addition, the Company holds a variable interest and is the primary beneficiary of other joint ventures and entities. The following table summarizes the carrying amounts of other entities' assets and liabilities included in the Company’s consolidated balance sheets at June 30, 2025 and December 31, 2024:
| Assets and Liabilities of Other Consolidated VIEs | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| Cash and cash equivalents | $ | 9 | $ | 22 | ||||
| Other current assets | 275 | 250 | ||||||
| Net property | 121 | 122 | ||||||
| Other noncurrent assets | 16 | 15 | ||||||
| Total assets 1 | $ | 421 | $ | 409 | ||||
| Current liabilities | $ | 27 | $ | 24 | ||||
| Other noncurrent obligations | 13 | 13 | ||||||
| Total liabilities 2 | $ | 40 | $ | 37 |
1.Restricted assets totaled $183 million and $192 million at June 30, 2025 and December 31, 2024, respectively.
2.All liabilities were nonrecourse at June 30, 2025 and December 31, 2024.
Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at June 30, 2025 and December 31, 2024 are adjusted for intercompany eliminations.
NOTE 23 – SEGMENTS AND GEOGRAPHIC REGIONS
Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:
| Sales to External Customers by Geographic Region | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| United States | $ | 3,725 | $ | 3,909 | $ | 7,671 | $ | 7,738 | ||||||
| EMEAI | 3,272 | 3,572 | 6,546 | 7,056 | ||||||||||
| Rest of World | 3,107 | 3,434 | 6,318 | 6,886 | ||||||||||
| Total | $ | 10,104 | $ | 10,915 | $ | 20,535 | $ | 21,680 |
Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:
| Long-Lived Assets by Geographic Region | Jun 30, 2025 | Dec 31, 2024 | ||||||
| In millions | ||||||||
| United States | $ | 15,050 | $ | 15,216 | ||||
| EMEAI | 2,785 | 2,726 | ||||||
| Rest of World | 4,641 | 4,062 | ||||||
| Total | $ | 22,476 | $ | 22,004 |
Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.
| Segment Operating EBIT 1 | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | ||||||||||
| In millions | ||||||||||||||
| Three months ended Jun 30, 2025 | ||||||||||||||
| Net sales | $ | 5,025 | $ | 2,786 | $ | 2,129 | $ | 9,940 | ||||||
| Cost of sales | 4,728 | 2,832 | 1,814 | 9,374 | ||||||||||
| SARD 2 | 221 | 116 | 147 | 484 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 7 | (39) | 1 | (31) | ||||||||||
| Other segment income (expense) items 3 | (12) | 16 | (17) | (13) | ||||||||||
| Segment Operating EBIT 4 | $ | 71 | $ | (185) | $ | 152 | $ | 38 | ||||||
| Three months ended Jun 30, 2024 | ||||||||||||||
| Net sales | $ | 5,515 | $ | 2,951 | $ | 2,243 | $ | 10,709 | ||||||
| Cost of sales | 4,616 | 2,803 | 1,915 | 9,334 | ||||||||||
| SARD 2 | 253 | 127 | 157 | 537 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 55 | (31) | 2 | 26 | ||||||||||
| Other segment income (expense) items 3 | 2 | 17 | (27) | (8) | ||||||||||
| Segment Operating EBIT 4 | $ | 703 | $ | 7 | $ | 146 | $ | 856 | ||||||
| Six months ended Jun 30, 2025 | ||||||||||||||
| Net sales | $ | 10,335 | $ | 5,641 | $ | 4,200 | $ | 20,176 | ||||||
| Cost of sales | 9,493 | 5,654 | 3,659 | 18,806 | ||||||||||
| SARD 2 | 461 | 243 | 298 | 1,002 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 46 | (97) | 1 | (50) | ||||||||||
| Other segment income (expense) items 3 | (14) | 40 | (43) | (17) | ||||||||||
| Segment Operating EBIT 4 | $ | 413 | $ | (313) | $ | 201 | $ | 301 | ||||||
| Six months ended Jun 30, 2024 | ||||||||||||||
| Net sales | $ | 10,945 | $ | 5,959 | $ | 4,395 | $ | 21,299 | ||||||
| Cost of sales | 9,213 | 5,579 | 3,809 | 18,601 | ||||||||||
| SARD 2 | 508 | 263 | 354 | 1,125 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 80 | (46) | 8 | 42 | ||||||||||
| Other segment income (expense) items 3 | 4 | 23 | (53) | (26) | ||||||||||
| Segment Operating EBIT 4 | $ | 1,308 | $ | 94 | $ | 187 | $ | 1,589 |
1.Significant expense categories are presented on an operating basis, net of the impact of significant items.
2.SARD includes selling, general and administrative and research and development expenses.
3.Other segment items includes amortization of intangibles and sundry income (expense) - net.
4.Segment Operating EBIT for TDCC for the three and six months ended June 30, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income (loss) before income taxes" is provided in the following table.
| Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes" | Three Months Ended | Six Months Ended | ||||||||||||
| In millions | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2024 | ||||||||||
| Segment Operating EBIT | $ | 38 | $ | 856 | $ | 301 | $ | 1,589 | ||||||
| + Corporate Operating EBIT | (59) | (37) | (92) | (96) | ||||||||||
| + Interest income | 39 | 42 | 67 | 107 | ||||||||||
| - Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 | ||||||||||
| + Significant items | (468) | (56) | (884) | (147) | ||||||||||
| Income (loss) before income taxes | $ | (659) | $ | 608 | $ | (1,033) | $ | 1,057 |
| Other Segment Information | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. 1 | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Three months ended Jun 30, 2025 | ||||||||||||||||||||
| Net sales | $ | 5,025 | $ | 2,786 | $ | 2,129 | $ | 9,940 | $ | 164 | $ | 10,104 | ||||||||
| Depreciation and amortization | $ | 369 | $ | 153 | $ | 192 | $ | 714 | $ | 10 | $ | 724 | ||||||||
| Capital expenditures | $ | 510 | $ | 102 | $ | 50 | $ | 662 | $ | — | $ | 662 | ||||||||
| Operating EBIT | $ | 71 | $ | (185) | $ | 152 | $ | 38 | $ | (59) | $ | (21) | ||||||||
| Three months ended Jun 30, 2024 | ||||||||||||||||||||
| Net sales | $ | 5,515 | $ | 2,951 | $ | 2,243 | $ | 10,709 | $ | 206 | $ | 10,915 | ||||||||
| Depreciation and amortization | $ | 343 | $ | 141 | $ | 191 | $ | 675 | $ | 7 | $ | 682 | ||||||||
| Capital expenditures | $ | 475 | $ | 170 | $ | 78 | $ | 723 | $ | — | $ | 723 | ||||||||
| Operating EBIT | $ | 703 | $ | 7 | $ | 146 | $ | 856 | $ | (37) | $ | 819 | ||||||||
| Six months ended Jun 30, 2025 | ||||||||||||||||||||
| Net sales | $ | 10,335 | $ | 5,641 | $ | 4,200 | $ | 20,176 | $ | 359 | $ | 20,535 | ||||||||
| Depreciation and amortization | $ | 729 | $ | 299 | $ | 392 | $ | 1,420 | $ | 18 | $ | 1,438 | ||||||||
| Capital expenditures | $ | 1,025 | $ | 231 | $ | 91 | $ | 1,347 | $ | — | $ | 1,347 | ||||||||
| Operating EBIT | $ | 413 | $ | (313) | $ | 201 | $ | 301 | $ | (92) | $ | 209 | ||||||||
| Six months ended Jun 30, 2024 | ||||||||||||||||||||
| Net sales | $ | 10,945 | $ | 5,959 | $ | 4,395 | $ | 21,299 | $ | 381 | $ | 21,680 | ||||||||
| Depreciation and amortization | $ | 714 | $ | 288 | $ | 384 | $ | 1,386 | $ | 16 | $ | 1,402 | ||||||||
| Capital expenditures | $ | 944 | $ | 332 | $ | 161 | $ | 1,437 | $ | — | $ | 1,437 | ||||||||
| Operating EBIT | $ | 1,308 | $ | 94 | $ | 187 | $ | 1,589 | $ | (96) | $ | 1,493 |
1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.
| Segment Asset Information | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Jun 30, 2025 | ||||||||||||||||||||
| Total assets | $ | 29,791 | $ | 12,252 | $ | 11,585 | $ | 53,628 | $ | 5,363 | $ | 58,991 | ||||||||
| Investments in nonconsolidated affiliates 1 | $ | 686 | $ | 386 | $ | 145 | $ | 1,217 | $ | 45 | $ | 1,262 | ||||||||
| Dec 31, 2024 | ||||||||||||||||||||
| Total assets | $ | 29,034 | $ | 11,928 | $ | 11,170 | $ | 52,132 | $ | 5,180 | $ | 57,312 | ||||||||
| Investments in nonconsolidated affiliates 1 | $ | 711 | $ | 367 | $ | 146 | $ | 1,224 | $ | 42 | $ | 1,266 |
1.See Note 10 for additional information regarding the Company's investments in nonconsolidated affiliates.
The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:
| Significant Items by Segment | |||||||||||||||||||||||||||||||||||
| In millions | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Mat. & Coatings | Operating Segment Total | Corp. | Total | |||||||||||||||||||||||||||||
| Three months ended Jun 30, 2025 | |||||||||||||||||||||||||||||||||||
| 2025 Restructuring Program severance and related benefit costs and asset related charges 1 | $ | (158) | $ | (89) | $ | (147) | $ | (394) | $ | (197) | $ | (591) | |||||||||||||||||||||||
| Implementation costs 2 | — | — | — | — | (5) | (5) | |||||||||||||||||||||||||||||
| Net gain on divestitures and asset sale 3 | — | 103 | — | 103 | — | 103 | |||||||||||||||||||||||||||||
| Litigation related charges, awards and adjustments 4 | — | — | — | — | 42 | 42 | |||||||||||||||||||||||||||||
| Indemnification and other transaction related costs 5 | — | — | — | — | (17) | (17) | |||||||||||||||||||||||||||||
| Total significant items by segment | $ | (158) | $ | 14 | $ | (147) | $ | (291) | $ | (177) | $ | (468) | |||||||||||||||||||||||
| Six months ended Jun 30, 2025 | |||||||||||||||||||||||||||||||||||
| Restructuring, implementation and efficiency costs, and asset related charges - net 6 | $ | — | $ | (1) | $ | — | $ | (1) | $ | (50) | $ | (51) | |||||||||||||||||||||||
| 2025 Restructuring Program severance and related benefit costs and asset related charges 1 | (158) | (89) | (147) | (394) | (404) | (798) | |||||||||||||||||||||||||||||
| Implementation costs 2 | — | — | — | — | (5) | (5) | |||||||||||||||||||||||||||||
| Net gain on divestitures and asset sale 3 | — | 103 | — | 103 | — | 103 | |||||||||||||||||||||||||||||
| Litigation related charges, awards and adjustments 4 | — | — | — | — | 42 | 42 | |||||||||||||||||||||||||||||
| Loss on early extinguishment of debt 7 | — | — | — | — | (60) | (60) | |||||||||||||||||||||||||||||
| Indemnification and other transaction related costs 5 | — | — | — | — | (115) | (115) | |||||||||||||||||||||||||||||
| Total significant items by segment | $ | (158) | $ | 13 | $ | (147) | $ | (292) | $ | (592) | $ | (884) |
1.Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program. See Note 5 for additional information.
2.Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's wholly owned subsidiary, Diamond Infrastructure Solutions.
3.Related to a gain on the sale of the soil fumigation product line. See Note 4 for additional information.
4.Includes a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters, partially offset by the settlement of a separate claim related to water storage district Groundwater Matters. See Note 14 for additional information.
5.Charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. The six months ended June 30, 2025 also includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 14 for additional information.
6.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The six months ended June 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 5 for additional information.
7.The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 13 for additional information.
| Significant Items by Segment | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Three months ended Jun 30, 2024 | ||||||||||||||||||||
| Restructuring, implementation and efficiency costs, and asset related charges - net 1 | $ | — | $ | — | $ | — | $ | — | $ | (56) | $ | (56) | ||||||||
| Six months ended Jun 30, 2024 | ||||||||||||||||||||
| Restructuring, implementation and efficiency costs, and asset related charges - net 1 | $ | (37) | $ | (8) | $ | — | $ | (45) | $ | (102) | $ | (147) | ||||||||
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The six months ended June 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets.
Previous: Cover and table of contents · Next: Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.